While the name Bioluminescence Ventures has emerged as an investor in various biotech funding announcements since at least last May, the venture firm officially emerged from stealth on Wednesday, unveiling $477 million in assets. Led by Kouki Harasaki, a former senior partner at Andreessen Horowitz, Bioluminescence has already put money
This content was originally published here.
